Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT03158103
Status:
COMPLETED
Last Update Posted:
2021-04-30
First Post:
2017-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-16
First Submit QC Date:
None
Study First Post Date:
2017-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-29
Last Update Post Date:
2021-04-30
Last Update Post Date Type:
ACTUAL